ResearcherID - CLICK HERE Scientific Journal Impact Factor (SJIF-2020) - CLICK HERE

TITLE:

DETERMINE THE FREQUENCY AND ASSOCIATED RISK FACTORS OF COGNITIVE IMPAIRMENT IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS

AUTHORS:

Imdad Ali Ansari, Tanveer Ahmed Ansari, Azizullah Jalbani, Rehmat Ali Wagon, Jawed Akhtar Samo, Aneel Kumar

ABSTRACT:

Objective: To determine the frequency of cognitive impairment and it associated risk factors in patients presented with systemic lupus erythematosus. Study Design: Cross-sectional study Place and Duration: Department of Medicine, Chandka Medical College Hospital Larkana from 1st July 2018 to 31st December 2019. Methods: Ninety five patients of either gender presented with systemic lupus erythematosus were enrolled in this study. Patients detailed medical history, demographics including age, sex, education level, socioeconomic status and co-morbidities were recorded after taking informed written consent. Frequency of cognitive impairment was examined by Mini-mental state examination. Predictors of cognitive impairment were examined. Results: Seventy five (78.95%) were females while 20 (21.05%) patients were males. Fifteen (15.79%) patients were ages <30 years, 29 (30.53%) had ages 31 to 45 years, 40 (42.11%) were ages 46 to 60 years and 11 (11.58%) had ages >60 years. Cognitive impairment was found in 22 (23.16%) patients. Among 22 cognitive impairment patients 17 (77.27%) had mild cognitive impairment and 5 (22.73%) had dementia. Cardiovascular disease, disease duration, low socio-economic status, and steroids use were the risk factors significantly associated with cognitive impairment (p-value <0.05), Conclusion: The frequency of cognitive impairment in systemic lupus erythematosus patients was high. Diabetes mellitus, cardiovascular disease, low socio-economic status and hydroxychloroquine were the major risk factors associated with cognitive impairment. Keywords: Systemic lupus erythematosus, Cognitive impairment, Cardiovascular disease, Socioeconomic status, Diabetes mellitus, Steroids.

Top
  • Follows us on
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.